Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 76

1.

All-cause mortality in HIV-positive adults starting combination antiretroviral therapy: correcting for loss to follow-up.

Anderegg N, Johnson LF, Zaniewski E, Althoff KN, Balestre E, Law M, Nash D, Shepherd BE, Yiannoutsos CT, Egger M; IeDEA, MeSH consortia..

AIDS. 2017 Apr;31 Suppl 1:S31-S40. doi: 10.1097/QAD.0000000000001321.

PMID:
28296798
2.

Incidence of Severe Neutropenia in HIV-Infected People Starting Antiretroviral Therapy in West Africa.

Leroi C, Balestre E, Messou E, Minga A, Sawadogo A, Drabo J, Maiga M, Zannou M, Seydi M, Dabis F, Jaquet A; IeDEA West Africa collaboration..

PLoS One. 2017 Jan 25;12(1):e0170753. doi: 10.1371/journal.pone.0170753. eCollection 2017.

PMID:
28122041
3.

Condom use and associated factors among men who have sex with men in Togo, West Africa.

Bakai TA, Ekouevi DK, Tchounga BK, Balestre E, Afanvi KA, Goilibe KB, Kassankogno Y, Pitche VP.

Pan Afr Med J. 2016 Mar 24;23:118. doi: 10.11604/pamj.2016.23.118.7492. eCollection 2016.

PMID:
27279945
4.

Mortality and survival patterns of people living with HIV-2.

Tchounga B, Ekouevi DK, Balestre E, Dabis F.

Curr Opin HIV AIDS. 2016 Sep;11(5):537-544.

PMID:
27254747
5.

Implementation of Tuberculosis Intensive Case Finding, Isoniazid Preventive Therapy, and Infection Control ("Three I's") and HIV-Tuberculosis Service Integration in Lower Income Countries.

Charles MK, Lindegren ML, Wester CW, Blevins M, Sterling TR, Dung NT, Dusingize JC, Avit-Edi D, Durier N, Castelnuovo B, Nakigozi G, Cortes CP, Ballif M, Fenner L; International epidemiology Databases to Evaluate AIDS (IeDEA) Collaboration..

PLoS One. 2016 Apr 13;11(4):e0153243. doi: 10.1371/journal.pone.0153243. eCollection 2016.

PMID:
27073928
6.

Immunologic response in treatment-naïve HIV-2-infected patients: the IeDEA West Africa cohort.

Balestre E, Ekouevi DK, Tchounga B, Eholie SP, Messou E, Sawadogo A, Thiébaut R, May MT, Sterne JA, Dabis F; International Epidemiological Database to Evaluate AIDS (IeDEA) West Africa Collaboration..

J Int AIDS Soc. 2016 Feb 8;19(1):20044. doi: 10.7448/IAS.19.1.20044. eCollection 2016.

PMID:
26861115
7.

Monitoring and switching of first-line antiretroviral therapy in adult treatment cohorts in sub-Saharan Africa: collaborative analysis.

Haas AD, Keiser O, Balestre E, Brown S, Bissagnene E, Chimbetete C, Dabis F, Davies MA, Hoffmann CJ, Oyaro P, Parkes-Ratanshi R, Reynolds SJ, Sikazwe I, Wools-Kaloustian K, Zannou DM, Wandeler G, Egger M; IeDEA southern Africa, east Africa, and west Africa..

Lancet HIV. 2015 Jul;2(7):e271-8. doi: 10.1016/S2352-3018(15)00087-9. Epub 2015 Jun 16.

PMID:
26423252
8.

Determinants of Weight Evolution Among HIV-Positive Patients Initiating Antiretroviral Treatment in Low-Resource Settings.

Huisin ʼt Veld D, Balestre E, Buyze J, Menten J, Jaquet A, Cooper DA, Dabis F, Yiannoutsos CT, Diero L, Mutevedzi P, Fox MP, Messou E, Hoffmann CJ, Prozesky HW, Egger M, Hemingway-Foday JJ, Colebunders R; International Epidemiologic Databases to Evaluate AIDS (IeDEA)..

J Acquir Immune Defic Syndr. 2015 Oct 1;70(2):146-54. doi: 10.1097/QAI.0000000000000691.

PMID:
26375465
9.

Impact of the Ebola epidemic on general and HIV care in Macenta, Forest Guinea, 2014.

Leuenberger D, Hebelamou J, Strahm S, De Rekeneire N, Balestre E, Wandeler G, Dabis F; IeDEA West Africa study group..

AIDS. 2015 Sep 10;29(14):1883-7. doi: 10.1097/QAD.0000000000000784.

PMID:
26372393
10.

Effect of cotrimoxazole prophylaxis on the incidence of malaria in HIV-infected children in 2012, in Abidjan, Côte d'Ivoire: a prospective cohort study.

Harouna AM, Amorissani-Folquet M, Eboua FT, Desmonde S, N'Gbeche S, Aka EA, Kouadio K, Kouacou B, Malateste K, Bosse-Amani C, Ahuatchi Coffie P, Leroy V; IeDEA paediatric West African Study Group..

BMC Infect Dis. 2015 Aug 7;15:317. doi: 10.1186/s12879-015-1009-6.

PMID:
26248711
11.

Determinants of durability of first-line antiretroviral therapy regimen and time from first-line failure to second-line antiretroviral therapy initiation.

Desmonde S, Eboua FT, Malateste K, Dicko F, Ekouévi DK, Ngbeché S, Koueta F, Sy HS, Renner L, Koumakpai SA, Leroy V; IeDEA Pediatric West African Working Group..

AIDS. 2015 Jul 31;29(12):1527-36. doi: 10.1097/QAD.0000000000000707.

PMID:
26244392
12.

Effect of Age at Antiretroviral Therapy Initiation on Catch-up Growth Within the First 24 Months Among HIV-infected Children in the IeDEA West African Pediatric Cohort.

Jesson J, Koumakpaï S, Diagne NR, Amorissani-Folquet M, Kouéta F, Aka A, Lawson-Evi K, Dicko F, Kouakou K, Pety T, Renner L, Eboua T, Coffie PA, Desmonde S, Leroy V; Paediatric WADA IeDEA Collaboration..

Pediatr Infect Dis J. 2015 Jul;34(7):e159-68. doi: 10.1097/INF.0000000000000734.

PMID:
25955835
13.

Severe morbidity after antiretroviral (ART) initiation: active surveillance in HIV care programs, the IeDEA West Africa collaboration.

Abo Y, Zannou Djimon M, Messou E, Balestre E, Kouakou M, Akakpo J, Ahouada C, de Rekeneire N, Dabis F, Lewden C, Minga A; IeDEA West Africa Collaboration..

BMC Infect Dis. 2015 Apr 9;15:176. doi: 10.1186/s12879-015-0910-3.

PMID:
25885859
14.

Addressing social issues in a universal HIV test and treat intervention trial (ANRS 12249 TasP) in South Africa: methods for appraisal.

Orne-Gliemann J, Larmarange J, Boyer S, Iwuji C, McGrath N, Bärnighausen T, Zuma T, Dray-Spira R, Spire B, Rochat T, Lert F, Imrie J; ANRS 12249 TasP Group..

BMC Public Health. 2015 Mar 1;15:209. doi: 10.1186/s12889-015-1344-y.

PMID:
25880823
15.

Detection and management of drug-resistant tuberculosis in HIV-infected patients in lower-income countries.

Ballif M, Nhandu V, Wood R, Dusingize JC, Carter EJ, Cortes CP, McGowan CC, Diero L, Graber C, Renner L, Hawerlander D, Kiertiburanakul S, Du QT, Sterling TR, Egger M, Fenner L; International epidemiological Databases to Evaluate AIDS (IeDEA)..

Int J Tuberc Lung Dis. 2014 Nov;18(11):1327-36. doi: 10.5588/ijtld.14.0106.

PMID:
25299866
16.

Incidence of pregnancy after antiretroviral therapy initiation and associated factors in 8 West African countries.

Burgos-Soto J, Balestre E, Minga A, Ajayi S, Sawadogo A, Zannou MD, Leroy V, Ekouevi DK, Dabis F, Becquet R; IeDEA West Africa Collaboration..

J Acquir Immune Defic Syndr. 2014 Oct 1;67(2):e45-54. doi: 10.1097/QAI.0000000000000279.

PMID:
25216079
17.

Antiretroviral treatment response of HIV-infected children after prevention of mother-to-child transmission in West Africa.

Ndondoki C, Dicko F, Ahuatchi Coffie P, Kassi Eboua T, Ekouevi DK, Kouadio K, Edmond Aka A, Malateste K, Dabis F, Amani-Bosse C, Toure P, Leroy V; Paediatric IeDEA West African Working Group..

J Int AIDS Soc. 2014 Jun 2;17:18737. doi: 10.7448/IAS.17.1.18737. eCollection 2014.

PMID:
24894377
18.

Association between age at antiretroviral therapy initiation and 24-month immune response in West-African HIV-infected children.

Desmonde S, Dicko F, Koueta F, Eboua T, Balestre E, Amani-Bosse C, Aka EA, Lawson-Evi K, Amorissani-Folquet M, Kouakou K, Koumakpai S, Renner L, Signaté Sy H, Leroy V; IeDEA West Africa Paediatric Collaboration..

AIDS. 2014 Jul 17;28(11):1645-55. doi: 10.1097/QAD.0000000000000272.

PMID:
24804858
19.

Reasons for hospitalization in HIV-infected children in West Africa.

Dicko F, Desmonde S, Koumakpai S, Dior-Mbodj H, Kouéta F, Baeta N, Koné N, Akakpo J, Signate Sy H, Ye D, Renner L, Lewden C, Leroy V; Pediatric IeDEA West Africa Working Group..

J Int AIDS Soc. 2014 Apr 22;17:18818. doi: 10.7448/IAS.17.1.18818. eCollection 2014.

PMID:
24763078
20.

Disease patterns and causes of death of hospitalized HIV-positive adults in West Africa: a multicountry survey in the antiretroviral treatment era.

Lewden C, Drabo YJ, Zannou DM, Maiga MY, Minta DK, Sow PS, Akakpo J, Dabis F, Eholié SP; IeDEA West Africa Collaboration..

J Int AIDS Soc. 2014 Apr 7;17:18797. doi: 10.7448/IAS.17.1.18797. eCollection 2014.

PMID:
24713375

Supplemental Content

Loading ...
Support Center